SOURCE: SECFilings.com

SECFilings.com

August 17, 2016 09:07 ET

SECFilings.com: Oculus Innovative Sciences (OCLS) Tackling Eczema From the Inside Out and Outside In

REDONDO BEACH, CA--(Marketwired - Aug 17, 2016) - SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an in-depth examination of Oculus Innovative Sciences' (NASDAQ: OCLS) unique and effective approach to the treatment of eczema.

Many may take skin for granted, but it is one of the most complex and important parts of the body. That is certainly not the case, though, for approximately one-third of Americans who suffer from some type of skin condition. Despite the advancements, especially with biologics for psoriasis, there is still an unmet need for many skin conditions, including atopic dermatitis and eczema, an umbrella term for conditions such as atopic dermatitis (the most common type of eczema), irritant and allergic contact dermatitis, and hand eczema. In all cases, eczema is characterized by red, irritated and inflamed skin. The National Eczema Association (NEA) estimates that 31.6 million people in the U.S. have symptoms of eczema, including about 18 million with moderate to severe eczema.

Without a "cure" for atopic dermatitis, management of each of the symptoms through a deep understanding of how the skin functions is the best answer. In April, Oculus launched its latest product for eczema, called Ceramax® Skin Barrier Cream, which is built on Lipogrid® technology.

Ceramax® utilizes a blend of ingredients, including leveraging the properties of physiological lipids to meet the goals of skin repair through an inside-out and outside-in approach. This is due to the fact the physiological lipids can be absorbed into the stratum corneum, with some reaching the viable epidermis while also protecting the outside of the skin while it heals.

To read the full article, which discusses both the science of why and how Ceramax® works along with Oculus' success in getting doctors to prescribe the new product, please click here: http://analysis.secfilings.com/articles/55-oculus-innovative-sciences-tackling-eczema-from-the-inside-out-and-outside-in

About SECFilings.com

Founded in 2004, SECFilings.com provides free real time filing alerts to over 600,000 registered members and offers services to help public companies grow their audience of interested investors.

Disclaimer:

Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns SECFilings.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://secfilings.com/Disclaimer.aspx.

Contact Information